-High prevalence of Lyme disease in animals in developed countries with substantial spending on veterinary care boosts growth of the Lyme disease treatment market
-Funding from government organizations and large corporations to develop treatment for Lyme disease to stimulate growth of the Lyme disease treatment market
ALBANY, N.Y., Dec. 2, 2021 /PRNewswire/ -- The increasing prevalence of Lyme disease in developed countries that receives funding from non-medico organizations to develop the treatment for the same is fuelling the growth of the Lyme disease treatment market. Lyme disease is the most common vector-borne disease in the U.S. with almost half a million cases reported each year. According to the Centers for Disease Control and Prevention, 20,000 to 30, 000 confirmed cases of Lyme disease are reported in the U.S. each year. The number of cases of Lyme disease have also increased steadily in Europe, reports the World Health Organization.
Lyme disease is prevalent in humans and animals, and the growing affection toward pets is leading to increased transmission of Lyme disease. Lyme disease is bacteria-borne and transferred to humans through the bite of infected blacklegged ticks. Headache, fever, and skin rash are common symptoms of Lyme disease, which can spread to the heart, joints, and neurotic system if not treated on time.
The factors are assessed for the Lyme disease treatment market, which is expected to reach US$ 3 Bn by 2031.
Lyme disease Treatment Market – Key Findings of the Report
Initiatives to Develop New Line of Treatment for Early Detection of Disease Underway
Clinical research such as the one based on new cytokine immunoassay for an earlier and improved examination of Lyme disease is underway in the Lyme disease treatment market. This involves use of advanced technologies for rapid point-of-care treatment for Lyme disease. New ways of identifying Lyme disease, early stage examination, accurate staging of diseases, and indications of successful treatment are some other objectives of clinical research initiatives within the Lyme disease treatment market.
Clinical trials that receive funding from medical organizations to study the effectiveness of prolonged antibiotic therapy for the treatment of Lyme disease are underway. Nonetheless, innovations for simple and effective Lyme disease treatments have been embraced by key players in the Lyme disease treatment market for the improving portfolio for the treatment of the disease. For instance, initiatives undertaken by the National Institutes of Health in multiple areas of research for the treatment of Lyme disease exhibit most people recover within weeks of completing a course of oral medicines when treated soon after the appearance of symptom.
Risk of Fatality of Secondary Stage Disease in Canines Receives Attention
The U.S. registers high number of cases of Lyme disease in canines, with some other geographical regions anticipated to register more bacteria-carrying ticks in canines. The symptoms of Lyme disease vary in animals with zero symptoms as well.
Loss of appetite, aches or swelled joints, fever, and swollen lymph joints are early signs of Lymph disease in animals, which, if left untreated, can lead to severe harm to the heart, nervous system, or kidneys. Lyme disease affecting the organs is the second most common symptom in dogs and is usually fatal. This accounts for attention for the treatment of Lyme disease among pet owners.
Lyme disease Treatment Market – Growth Drivers
Rising pet ownership and increasing expenditure on veterinary care are driving the Lyme disease treatment market
Clinical research supported by government organizations and large corporations to develop treatment for Lyme disease prevalent in humans and animals fuels the growth of the Lyme disease treatment market
Lyme disease Treatment Market – Key Players
Some key players operating in the Lyme disease treatment market are GlaxoSmithKline plc, Novartis AG, Almirall LLC, Boehringer Ingelheim International GmbH, Lupin Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Orion Corporation, F. Hoffmann-La Roche Ltd., Mayne Pharma, Galderma Laboratories L.P., Chartwell Pharmaceuticals, and Perrigo Company plc.
The Lyme disease treatment market is segmented as follows;
Lyme disease Treatment Market, by Treatment Type
Lyme disease Treatment Market, by Type of Bacteria
Lyme disease Treatment Market, by Route of Administration
Lyme disease Treatment Market, by Application
Lyme disease Treatment Market, by Distribution Channel
Lyme disease Treatment Market, by Region
Rest of the Europe
Australia & New Zealand
Rest of Asia Pacific
Rest of Latin America
Middle East & Africa
Rest of Middle East & Africa
Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Industry Research Reports by Transparency Market Research:
Von Willebrand Disease Treatment Market: Research and development activities are set to play an important role in augmenting the growth of the global von Willebrand disease treatment market during the assessment period. The entry of new therapies and von Willebrand disease treatment, as a result of research programs and initiatives, is expected to provide a considerable boost to the global von Willebrand disease treatment market.
FFPE Tissue Samples Market: This report analyzes the current scenario and future prospects of the global FFPE tissue samples market. FFPE is a form of preparation and preservation for biopsy specimens that helps in diagnostic/drug development, experimental research, and examination.
Plant-based Vaccines Market: The global plant-based vaccines market for the historical period of 2017–2019 and the forecast period of 2021–2031, increase in incidence of infections, government initiatives for expansion of vaccination coverage, and government funding for vaccine development are projected to drive the global plant-based vaccines market in the near future
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.